Previous studies have shown that the combined effects of HbA1c and hs-CRP are associated with advanced subclinical carotid atherosclerosis progression (15), cardiovascular risks (16), and coronary artery diseases (17). The gene discussed is CRP; the disease is carotid atherosclerosis.